We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

1 Day ACHL 0.72% DJIA -0.45% Russell 2K -1.59% Health Care/Life Sciences 0.59% ...

LONDON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL) (the Company) today announced that it has formally notified The Nasdaq Stock Market LLC (Nasdaq) of its intention ...

Achilles Therapeutics plc has announced its decision to voluntarily delist its American Depositary Shares (ADSs) from Nasdaq and to deregister the ADSs from the SEC due to a planned members ...

Achilles Therapeutics (ACHL) has formally notified The Nasdaq Stock Market of its intention to voluntarily delist its American Depositary ...

LONDON - Achilles Therapeutics plc (NASDAQ:ACHL), a biopharmaceutical company with a market capitalization of $56.7 million, has announced its plan to voluntarily delist its American Depositary ...

Achilles Therapeutics (ACHL) announced that it has transferred the commercial license of data and samples from the TRACERx Non-Small Cell Lung Cancer study to AstraZeneca (AZN). TRACERx ...

LONDON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL) today announced that on November 15, 2024, the Listing Qualifications department of the Nasdaq Stock Market LLC ...

LONDON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL) (the Company) today announced that it has formally notified The Nasdaq Stock Market LLC (Nasdaq) of its intention to ...